Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Japon1003
N. Takahashi11
Japon Sauf N. Takahashi" 992
N. Takahashi Sauf Japon" 0
Japon Et N. Takahashi 11
Japon Ou N. Takahashi 1003
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
002A27 T. Kojima ; K. Funahashi ; N. Takahashi ; D. Kato ; H. Matsubara ; Y. Hattori ; Y. Yabe [Japon] ; N. IshiguroTHU0124 Importance of monitoring of C-reactive protein level to predict achievement of better clinical outcome during treatment with tocilizumab in patients with rheumatoid arthritis
002B40 Y. Kanayama ; T. Kojima ; Y. Hirano [Japon] ; N. Takahashi ; K. Funahashi ; D. Kato ; H. Matsubara ; Y. Hattori ; Y. Oishi [Japon] ; N. IshiguroSAT0155 Radiographic progression of cervical lesions and hands in patients with rheumatoid arthritis receiving infliximab treatment from japanese tbc registry; two years of follow-up
002B52 T. Kojima [Japon] ; N. Takahashi [Japon] ; K. Funahashi [Japon] ; D. Kato [Japon] ; Y. Hattori [Japon] ; M. Hanabayashi [Japon] ; N. Asai [Japon] ; N. Ishiguro [Japon]SAT0139 Importance of Concomitant MTX Use During Treatment with Tocilizumab in Patients with Rheumatoid Arthritis
002B57 S. Hirabara [Japon] ; T. Kojima [Japon] ; N. Takahashi [Japon] ; M. Hanabayashi [Japon] ; K. Terabe [Japon] ; Y. Yoshioka [Japon] ; N. Ishiguro [Japon]SAT0134 Clinical Efficacy of Abatacept in Rheumatoid Arthritis Patients with Prior Use of Tocilizumab; Results from Japanese Multicenter Registry System TBCR
002B67 M. Hanabayashi [Japon] ; T. Kojima [Japon] ; N. Takahashi [Japon] ; K. Funahashi [Japon] ; D. Kato [Japon] ; Y. Hattori [Japon] ; N. Ishiguro [Japon]SAT0118 The Clinical Outcome of Abatacept Treatment in Biologic NaÏVe Patients with Rheumatoid Arthritis in Multi-Center Clinical Practice
002C12 S. Asai [Japon] ; T. Kojima [Japon] ; N. Takahashi [Japon] ; K. Funahashi [Japon] ; D. Katoh [Japon] ; Y. Hattori [Japon] ; M. Hanabayashi [Japon] ; K. Terabe [Japon] ; N. Ishiguro [Japon]SAT0013 Risk Factors for Progression of Large Joint Destruction in Patients with Rheumatoid Arthritis Based on Incident Rate of Joint Surgery During Treatment with Biologics
003066 Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. IshiguroAB0591 Analysis of rheumatoid arthritis patients who were treated with abatacept with rapid effectiveness from japanese multicenter registry system of biological therapy
003093 N. Takahashi [Japon] ; T. Kojima [Japon] ; K. Funahashi [Japon] ; D. Kato [Japon] ; H. Matsubara [Japon] ; Y. Hattori [Japon] ; N. Ishiguro [Japon]AB0563 Impact of the history and the type of previous biologic treatment on abatacept efficacy in rheumatoid arthritis patients
003143 A. Kaneko ; N. Takahashi ; D. Kida ; Y. Hirano [Japon] ; H. Ishikawa ; T. Kojima ; N. IshiguroAB0515 Predictors of clinical remission (DAS28CRP<2.6) in patients with RA who were treated with abatacept
003184 Y. Hirano ; N. Takahashi ; A. Kaneko [Japon] ; D. Kida [Japon] ; Y. Oishi ; T. Kojima ; N. IshiguroAB0339 A retrospective study on rapidness of efficacy in abatacept terapy in patients with rheumatoid arthritis from japanese multicenter registry system
003187 Y. Kanayama ; T. Kojima ; Y. Hirano ; Y. Yabe [Japon] ; N. Takahashi ; K. Funahashi ; Y. Oishi ; N. IshiguroAB0336 Radiographic progression of cervical lesions in patients with rheumatoid arthritis receiving tocilizumab treatment comparison with infliximab treatment from japanese tbcr

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021